| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | ||||||||||
1,230,593 | 1,088,205 | 1,023,513 | 1,036,273 | 1,090,630 | 1,198,223 | 1,192,680 | 1,123,301 | 1,000,903 | 789,695 | 645,767 |
Cost of sales | ||||||||||
613,537 | 528,051 | 506,292 | 536,109 | 579,825 | 603,893 | 569,482 | 515,324 | 464,493 | 364,631 | 337,720 |
Restructuring charges | ||||||||||
- | - | - | - | - | 3,985 | - | - | - | 1,300 | 7,086 |
Gross profit | ||||||||||
617,056 | 560,154 | 517,221 | 500,164 | 510,805 | 590,345 | 623,198 | 607,977 | 536,410 | 423,764 | 300,961 |
Selling, general and administrative expenses | ||||||||||
488,407 | 495,028 | 494,601 | 503,174 | 567,823 | 565,712 | 549,154 | 460,393 | 404,803 | 342,961 | 311,592 |
Restructuring charges | ||||||||||
- | - | - | - | - | 20,532 | - | - | - | 2,539 | 7,623 |
Asset impairments | ||||||||||
0 | 2,182 | 5,284 | 3,144 | 15,306 | 8,827 | 10,949 | 1,410 | 528 | 141 | 26,085 |
Charitable contributions expense | ||||||||||
- | - | - | - | - | - | - | - | - | - | 7,510 |
Income from operations | ||||||||||
128,649 | 62,944 | 17,336 | -6,154 | -72,324 | -4,726 | 63,095 | 146,174 | 131,079 | 78,123 | -51,184 |
Foreign currency losses, net | ||||||||||
-1,323 | 1,318 | 563 | -2,454 | -3,332 | -4,885 | -4,678 | -2,500 | 4,886 | 2,325 | 665 |
Interest income | ||||||||||
601 | 1,281 | 870 | 692 | 967 | 1,664 | 2,432 | 1,697 | 957 | - | - |
Interest expense | ||||||||||
8,636 | 955 | 869 | 836 | 969 | 806 | 1,016 | 837 | 853 | 657 | 1,495 |
Gain on charitable contributions | ||||||||||
- | - | - | - | - | - | - | - | - | - | -3,163 |
Other income, net | ||||||||||
31 | 569 | 280 | 1,539 | 914 | 204 | 126 | 1,014 | 621 | 1,001 | -895 |
Income before income taxes | ||||||||||
119,322 | 65,157 | 18,180 | -7,213 | -74,744 | -8,549 | 59,959 | 145,548 | 136,690 | 80,792 | -48,621 |
Income tax expense | ||||||||||
-175 | 14,720 | 7,942 | 9,281 | 8,452 | -3,623 | 49,539 | 14,205 | 23,902 | 13,066 | -6,543 |
Net income | ||||||||||
119,497 | 50,437 | 10,238 | -16,494 | -83,196 | -4,926 | 10,420 | 131,343 | 112,788 | 67,726 | -42,078 |
Dividends on Series A convertible preferred stock | ||||||||||
0 | 108,224 | 12,000 | 12,000 | 11,833 | 11,301 | - | - | - | - | - |
Dividend equivalents on Series A convertible preferred shares related to redemption value accretion and beneficial conversion feature | ||||||||||
0 | 11,429 | 3,532 | 3,244 | 2,978 | 2,735 | - | - | - | - | - |
Net income (loss) attributable to common stockholders | ||||||||||
119,497 | -69,216 | -5,294 | -31,738 | -98,007 | -18,962 | 10,420 | 131,343 | - | - | - |
Net income per common share: | ||||||||||
Basic (in dollars per share) | ||||||||||
1.70 | -1.01 | -0.07 | -0.43 | -1.30 | -0.22 | 0.12 | 1.46 | 1.27 | 0.78 | -0.49 |
Diluted (in dollars per share) | ||||||||||
1.66 | -1.01 | -0.07 | -0.43 | -1.30 | -0.22 | 0.12 | 1.44 | 1.24 | 0.76 | -0.49 |
Weighted average common shares outstanding: | ||||||||||
Basic (in shares) | ||||||||||
70,357 | 68,421 | 72,255 | 73,371 | 75,604 | - | - | - | - | - | - |
Diluted (in shares) | ||||||||||
71,771 | 68,421 | 72,255 | 73,371 | 75,604 | - | - | - | - | - | - |